Literature DB >> 7488471

Is thrombolytic therapy really better than conventional treatment in acute inferior myocardial infarction?

H S Lee.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7488471      PMCID： PMC484063     

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  16 in total

1.  Quantitative study on the size of coronary artery supplying areas postmortem.

Authors:  H Kalbfleisch; W Hort
Journal:  Am Heart J       Date:  1977-08       Impact factor: 4.749

Review 2.  Inferior myocardial infarction. High-risk subgroups.

Authors:  P B Berger; T J Ryan
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

3.  Precordial ST segment depression predicts a worse prognosis in inferior infarction despite reperfusion therapy. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.

Authors:  E R Bates; P M Clemmensen; R M Califf; L E Gorman; L G Aronson; B S George; D J Kereiakes; E J Topol
Journal:  J Am Coll Cardiol       Date:  1990-12       Impact factor: 24.094

4.  Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators.

Authors:  G B Habib; J Heibig; S A Forman; B G Brown; R Roberts; M L Terrin; R Bolli
Journal:  Circulation       Date:  1991-03       Impact factor: 29.690

5.  Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction.

Authors:  H D White; R M Norris; M A Brown; M Takayama; A Maslowski; N M Bass; J A Ormiston; T Whitlock
Journal:  N Engl J Med       Date:  1987-10-01       Impact factor: 91.245

6.  Coronary anatomy and left ventricular function in the first 12 hours of acute myocardial infarction: the Western Washington Randomized Intracoronary Streptokinase Trial.

Authors:  M L Stadius; C Maynard; J K Fritz; K Davis; J L Ritchie; F Sheehan; J W Kennedy
Journal:  Circulation       Date:  1985-08       Impact factor: 29.690

7.  Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.

Authors:  D B Mark; M A Hlatky; R M Califf; C D Naylor; K L Lee; P W Armstrong; G Barbash; H White; M L Simoons; C L Nelson
Journal:  N Engl J Med       Date:  1995-05-25       Impact factor: 91.245

8.  Multicenter trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: effects on infarct size and left ventricular function.

Authors:  J P Bassand; J Machecourt; J Cassagnes; T Anguenot; R Lusson; E Borel; P Peycelon; E Wolf; D Ducellier
Journal:  J Am Coll Cardiol       Date:  1989-04       Impact factor: 24.094

9.  Intravenous streptokinase for acute myocardial infarction. Effects on global and regional systolic function.

Authors:  G V Martin; F H Sheehan; M Stadius; C Maynard; K B Davis; J L Ritchie; J W Kennedy
Journal:  Circulation       Date:  1988-08       Impact factor: 29.690

10.  Prognostic significance of the extent of myocardial injury in acute myocardial infarction treated by streptokinase (the GISSI trial).

Authors:  F Mauri; M Gasparini; L Barbonaglia; E Santoro; M Grazia Franzosi; G Tognoni; F Rovelli
Journal:  Am J Cardiol       Date:  1989-06-01       Impact factor: 2.778
View more
  1 in total

Review 1.  Inferior ST-Elevation Myocardial Infarction Presenting When Urgent Primary Percutaneous Coronary Intervention Is Unavailable: Should We Adhere to Current Guidelines?

Authors:  Yochai Birnbaum; Glenn N Levine; John French; Juan Carlos Kaski; Dan Atar; Mahboob Alam; David Hasdai; Hani Jneid; Barry F Uretsky
Journal:  Cardiovasc Drugs Ther       Date:  2020-07-15       Impact factor: 3.727
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.